Zoledronic acid is not equally potent on osteoclasts generated from different individuals - osteoclasts from smokers are less sensitive

Zoledronic acid is not equally potent on osteoclasts generated from different individuals - osteoclasts from smokers are less sensitive

Bibliographic Details
Main Authors:	Anais M.J. Møller, Jean-Marie Delaissé, Jacob B. Olesen, Troels Bechmann, Jonna S. Madsen, Luisa M. Canto, Silvia R. Rogatto, Kent Søe
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Bone Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352187220304344

Similar Items

A variability in response of osteoclasts to zoledronic acid is mediated by smoking-associated modification in the DNA methylome
by: Qihua Tan, et al.
Published: (2023-03-01)

Fusion Potential of Human Osteoclasts In Vitro Reflects Age, Menopause, and In Vivo Bone Resorption Levels of Their Donors—A Possible Involvement of DC-STAMP
by: Anaïs M. J. Møller, et al.
Published: (2020-09-01)

The Mechanism Switching the Osteoclast From Short to Long Duration Bone Resorption
by: Jean-Marie Delaisse, et al.
Published: (2021-03-01)

Epigenome-wide association study shows that smoking alters DNA methylation in blood cells triggering aggressive bone resorption of osteoclasts in vivo and in vitro
by: Salah Eddine Masmoudi, et al.
Published: (2021-04-01)

Real-time analysis of osteoclast resorption and fusion dynamics in response to bone resorption inhibitors
by: Preety Panwar, et al.
Published: (2024-03-01)

How zoledronic acid improves osteoporosis by acting on osteoclasts
by: Biao Wang, et al.
Published: (2022-08-01)

Transcriptional reprogramming during human osteoclast differentiation identifies regulators of osteoclast activity
by: Morten S. Hansen, et al.
Published: (2024-01-01)

The Capacity of Magnesium to Induce Osteoclast Differentiation Is Greatly Enhanced by the Presence of Zoledronate
by: Silvia Ricchiuto, et al.
Published: (2023-09-01)

Alendronate and ibandronate affect osteoclast formation and size differently from risedronate and zoledronate
by: Mabilleau, G, et al.
Published: (2011)

Osteoclasts’ Ability to Generate Trenches Rather Than Pits Depends on High Levels of Active Cathepsin K and Efficient Clearance of Resorption Products
by: Xenia G. Borggaard, et al.
Published: (2020-08-01)

Zoledronic Acid Inhibits the Capacity of Myeloid-Immune Suppressor Cells in Myeloma to Form Osteoclasts.
by: Zhuang, J, et al.
Published: (2008)

Osteoclast Fusion: Physiological Regulation of Multinucleation through Heterogeneity—Potential Implications for Drug Sensitivity
by: Kent Søe
Published: (2020-10-01)

Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review
by: Lianwei Wang, et al.
Published: (2020-11-01)

Zoledronic acid promotes osteoclasts ferroptosis by inhibiting FBXO9-mediated p53 ubiquitination and degradation
by: Xingzhou Qu, et al.
Published: (2021-12-01)

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.
by: Mabilleau, G, et al.
Published: (2009)

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
by: Mabilleau, G, et al.
Published: (2009)

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.
by: Guillaume Mabilleau, et al.
Published: (2009-01-01)

Osteoclasts and Microgravity
by: John Kelly Smith
Published: (2020-09-01)

Estrogen receptor gene expression in osteoclasts loss with osteoclast maturation.
by: Oreffo, R, et al.
Published: (1997)

Spatial Organization of Osteoclastic Coupling Factors and Their Receptors at Human Bone Remodeling Sites
by: Xenia G. Borggaard, et al.
Published: (2022-06-01)

The effects of seeding density and osteoclastic supplement concentration on osteoclastic differentiation and resorption
by: Stefan J.A. Remmers, et al.
Published: (2023-06-01)

Gastric inhibitory polypeptide (GIP) decreases bone resorptive activity of human osteoclasts in vitro
by: Morten Steen Svarer Hansen, et al.
Published: (2021-04-01)

The osteoclast--what's new?
by: Athanasou, N
Published: (2011)

Sexual Dimorphism in Osteoclasts
by: Joseph Lorenzo
Published: (2020-09-01)

Humoral factors act directly on circulating osteoclast precursors to control osteoclast formation
by: Hirayama, T, et al.
Published: (2000)

Bilirubin increases the viability of osteoclasts and up-regulates osteoclast-related microRNAs
by: Susana Jurado, et al.
Published: (2021-04-01)

Ninjurin1 positively regulates osteoclast development by enhancing the survival of prefusion osteoclasts
by: Sung-Jin Bae, et al.
Published: (2019-01-01)

M-CSF potently augments RANKL-induced resorption activation in mature human osteoclasts.
by: Jason M Hodge, et al.
Published: (2011-01-01)

Osteosarcoma and Metastasis Associated Bone Degradation—A Tale of Osteoclast and Malignant Cell Cooperativity
by: Kirstine Sandal Nørregaard, et al.
Published: (2021-06-01)

Formation and isolation of human osteoclasts
by: Kudo, O, et al.
Published: (2001)

Osteoclast function and its control.
by: Zaidi, M, et al.
Published: (1993)

The immunophenotype of osteoclasts and macrophage polykaryons
by: Maggiani, F, et al.
Published: (2011)

The immunophenotype of osteoclasts and macrophage polykaryons.
by: Maggiani, F, et al.
Published: (2011)

Osteoclast differentiation in rheumatoid arthritis
by: Kazuhiro Yokota
Published: (2024-01-01)

Glycobiology in osteoclast differentiation and function
by: Shufa Yang, et al.
Published: (2023-10-01)

Effects Of Prostacyclın In Osteoclastıc Actıvatıon
by: Yalçın Işımer, et al.
Published: (1990-11-01)

The Effects Of The Analgesıcs On The Osteoclastıc Actıvıty
by: Yalçın Işımer, et al.
Published: (1989-04-01)

Myosins in Osteoclast Formation and Function
by: Beth S. Lee
Published: (2018-11-01)

The Role of Osteoclasts in Psoriatic Arthritis
by: Zhen-Zhen Wang, et al.
Published: (2021-12-01)

Bone is not essential for osteoclast activation.
by: Karen Fuller, et al.
Published: (2010-09-01)